Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma

被引：0
作者：
Chun-Teng Huang
Chia-Jen Liu
Po-Shen Ko
Han-Tsung Liu
Yuan-Bin Yu
Liang-Tsai Hsiao
Jyh-Pyng Gau
Cheng-Hwai Tzeng
Tzeon-Jye Chiou
Jin-Hwang Liu
Muh-Hwa Yang
Ling-Ju Huang
Chun-Yu Liu
机构：
[1] Taipei Veterans General Hospital,Division of Hematology & Oncology, Department of Medicine
[2] National Yang-Ming University School of Medicine,Division of Transfusion Medicine, Department of Medicine
[3] Taipei Veterans General Hospital,Division of Hematology & Oncology, Department of Medicine
[4] Yang-Ming Branch of Taipei City Hospital,Division of General Medicine, Department of Medicine
[5] Taipei Veterans General Hospital,Division of Medical Oncology, Department of Oncology
[6] Taipei Veterans General Hospital,undefined
来源：
BMC Infectious Diseases | / 17卷
关键词：
Bloodstream infection; Multiple myeloma; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Patient characteristics associated with dose modifications for VRd among newly diagnosed multiple myeloma patients
    Ran, Tao
    Medhekar, Rohan
    Fu, Alex Z.
    Patel, Sharmila
    Kaila, Shuchita
    FUTURE ONCOLOGY, 2022, 18 (36) : 3983 - 3991
  • [32] Thrombosis events in Chinese patients with newly diagnosed multiple myeloma
    Li, Panpan
    Xu, Bei
    Xu, Jiadai
    Wang, Yawen
    Yang, Yang
    Wang, Wenjing
    Maihemaiti, Aiziguli
    Li, Jing
    Xu, Tianhong
    Ren, Liang
    Lan, Tianwei
    Zhou, Chi
    Wang, Pu
    Liu, Peng
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3809 - 3820
  • [33] Comparison of trace elements in peripheral blood and bone marrow of newly diagnosed multiple myeloma patients
    Kul, Ayse Nilgun
    Ozturk Kurt, Bahar
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [34] Clinical Characteristics and Risk Factors for Pleural Effusion in Patients with Multiple Myeloma
    Kang, Yu
    Hou, Zi-Liang
    Yang, Guang-Zhong
    Wang, Xiao-Juan
    Chen, Wen-Ming
    Shi, Huan-Zhong
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 649 - 657
  • [35] Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
    Mersin, Sinan
    Geduk, Ayfer
    Mehtap, Ozgur
    Tarkun, Pinar
    Unal, Serkan
    Polat, Merve Gokcen
    Aygun, Kemal
    Yenihayat, Emel Merve
    Albayrak, Hayrunnisa
    Hacihanifioglu, Abdullah
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (03) : 211 - 217
  • [36] The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
    Mielnik, Michal
    Szudy-Szczyrek, Aneta
    Homa-Mlak, Iwona
    Mlak, Radoslaw
    Podgajna-Mielnik, Martyna
    Goracy, Aneta
    Malecka-Massalska, Teresa
    Hus, Marek
    BIOMEDICINES, 2023, 11 (11)
  • [37] A Report of 134 Newly Diagnosed Multiple Myeloma Patients with Renal Impairment
    Liu, Aijun
    Yang, Guangzhong
    Geng, Chuanying
    Wang, Huijuan
    Li, Lihong
    Li, Yanchen
    Wu, Yin
    Tian, Ying
    Leng, Yun
    Wang, Guorong
    Gao, Wen
    Chen, Wenming
    ACTA HAEMATOLOGICA, 2016, 135 (03) : 140 - 145
  • [38] The Significance of Inflammatory Markers in the Prognosis of Newly Diagnosed Multiple Myeloma Patients
    Gui, Lin
    Wang, Fei
    Shi, Jinning
    Chen, Baoan
    BLOOD, 2020, 136
  • [39] STRATEGIES FOR SELECTING THE OPTIMAL TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Steinbach, Mary
    Richards, Tiffany
    Faiman, Beth
    SEMINARS IN ONCOLOGY NURSING, 2017, 33 (03) : 254 - 264
  • [40] The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics
    Pan, Qingrong
    Zhang, Yeqing
    Zhang, Wenkai
    Hu, Yanjin
    Chen, Zhe
    Liu, Aijun
    Wang, Guang
    ENDOCRINE PRACTICE, 2021, 27 (03) : 236 - 240
12345